Surgery Doctors in Johnston, RI Accepting Medicare

7 Surgery doctors found. Showing 1 - 7

Dr. Dieter Pohl, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Rhode Island Surgeons Inc, 1539 Atwood Ave Suite 201, Johnston, RI 02919 Phone: 401-521-6310    Fax: 401-861-9596

John A Phillip, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave, Suite 245, Johnston, RI 02919 Phone: 401-443-5559    Fax: 401-443-5562

Thomas Robert Rocco, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1526 Atwood Ave Ste 200, Johnston, RI 02919 Phone: 401-404-2975    Fax: 401-404-2976

Jeannine Giovanni, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Rhode Island Surgeons, Inc, 1539 Atwood Avenue Suite 201, Johnston, RI 02919 Phone: 401-521-6310    Fax: 401-861-9596

Dr. Daniel Marcus Christian, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave Ste 245, Johnston, RI 02919 Phone: 401-521-6080    Fax: 401-521-6092

Dr. Michael Leh Lin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave Ste 245, Johnston, RI 02919 Phone: 401-521-6080

Dr. Paul F Lentrichia, Surgery Medicare: Accepting Medicare Assignments Practice Location: Rhode Island Surgeons Inc, 1539 Atwood Avenue Suite 201, Johnston, RI 02919 Phone: 401-521-6310    Fax: 401-861-9596

News Archive

PrediXcan method improves detection of genes linked to complex diseases, biological traits of interest

A new computational method developed by scientists from the University of Chicago improves the detection of genes that are likely to be causal for complex diseases and biological traits. The method, PrediXcan, estimates gene expression levels across the whole genome - a better measure of biological action than single mutations - and integrates it with genome-wide association study (GWAS) data.

Genethon announces dosing of first patient at pediatric clinical trial platform for neuromuscular diseases

A first participant was dosed at I-Motion, the pediatric clinical trial platform for neuromuscular diseases located at Trousseau hospital in Paris, as part of the gene therapy trial in Duchenne muscular dystrophy (DMD) conducted by Genethon.

Genia Technologies receives $5M grant from NIH to develop nanopore-based DNA sequencing platform

Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies – The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH).

State highlights: Los Angeles' new mental health program; N.C. considers Medicaid expansion; N.Y. nurses push for more staff

The $756,000 initiative marks one of the county's most significant attempts to find a better way to treat people who have mental illness and wind up in the criminal justice system by offering them transitional housing, medical treatment and job-hunting help. Officials say the pilot program will start in Van Nuys and initially help 50 people at a time, but it is expected to spread throughout the county and could accommodate up to 1,000 people at once (Gerber, 9/17).

EpiCept to receive $0.97M in public offering

EpiCept Corporation announced today that it has entered into a definitive agreement with a single life science focused institutional investor for the purchase of 1,065 shares of its new Series B 0% Convertible Preferred Stock at $1,000 per share, which are convertible into an aggregate of approximately 6.3 million shares of its common stock, and five-year warrants to purchase up to approximately 3.1 million shares of its common stock at an exercise price of $0.17 per share that are immediately exercisable.

Read more Medical News

› Verified 3 days ago